Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Biolase logo — BIOLASE is the global market leader in all-tissue & soft-tis...

Biolase

BIOLASE is the global market leader in all-tissue & soft-tissue dental laser systems that are #AdvancingDentistry.

Founded 1987 United States Foothill Ranch, United States 410 employees Post-IPO Debt Total: $121.08M Biotechnology, Health Care +3

General Information

Company Name Biolase
Founded Year 1987
Location United States Foothill Ranch, United States
Founders / Decision Makers
Team member Team member
Employees 410
Industries Biotechnology, Health Care, Manufacturing +2
Funding Stage Post-IPO Debt
Business Model B2B, B2B2C, E Commerce
Revenue Model Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Biolase. To contact Biolase, visit BIOLASE.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Biolase

BIOLASE, founded in 1987, is a leading global player in the dental medical device industry, headquartered in the United States. Known for its innovative approach, the company stands out as the global market leader in all-tissue and soft-tissue dental laser systems, with the mission of Advancing Dentistry.

The company's core competency lies in its proprietary dental laser systems, which have been adopted by dental professionals worldwide, with sales exceeding 36,200 units across over 90 countries. These lasers are renowned for their ability to perform minimally invasive procedures with better clinical outcomes compared to traditional instruments, catering to a wide spectrum of dental needs from cosmetic to surgical applications.

BIOLASE operates in multiple industries, including Biotechnology, Health Care, Manufacturing, Medical Devices, and 3D Printing. The investment landscape saw a recent $7.00M Post-IPO Debt investment in February 2024, underscoring continued investor confidence in the company's growth potential and market leadership.

Taxonomy: Dental Lasers, All-Tissue Lasers, Soft-Tissue Lasers, WaterLase Technology, Minimally Invasive Dentistry, Cosmetic Dentistry, Restorative Dentistry, Surgical Applications, Biological Dentistry, Digital Imaging, 3D Cone Beam, Digital Intraoral Scanner, Veterinary Lasers, Er:Cr:YSGG Laser Systems, Diode Laser Systems

Services & Products

All-Tissue Lasers
Soft-Tissue Lasers
Dental Laser Training
Customer Service
Product Maintenance and Support

Target Customers

Dentists Dental Hygienists Dental Clinics Oral Surgeons Pediatric Dentists

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $7.00M -
13 Feb 2024
Post IPO Equity $1.40M -
06 Dec 2023
Post IPO Debt $4.50M -
13 Sep 2023
Post IPO Debt $4.50M -
24 May 2023
Post IPO Equity $5.76M -
10 Jan 2023
Post IPO Equity $6.50M -
28 Jun 2022
Post IPO Equity $14.40M -
04 Feb 2021
Post IPO Debt $6.00M -
08 Mar 2018
Post IPO Equity $12.00M -
30 Nov 2017
Post IPO Equity $10.00M 1
Oracle
Oracle
01 Aug 2016

View All 13 Funding Rounds

Biolase Alternatives & Competitors

Biolase vs
LEIXIR DENTAL LABORATORY GROUP
LEIXIR DENTAL LABORATORY GROUP United States

Global Dental Lab Network

Private Equity
510 employees
Health Care, Medical Devices
Biolase vs
DentlyTec
DentlyTec Israel

Revolutionizing digital dentistry by harnessing the power of subgingival imaging.

31 employees
Health Care, Medical Devices

FAQ About Biolase

BIOLASE is the global market leader in all-tissue & soft-tissue dental laser systems that are #AdvancingDentistry.
Biolase was founded in 1987.
Biolase is headquartered in Foothill Ranch, United States.
Biolase operates in Biotechnology, Health Care, Manufacturing, Medical Devices and 3D Printing. Its work centres on Dental Lasers, All-Tissue Lasers, Soft-Tissue Lasers and WaterLase Technology. Its customers include Dentists, Dental Hygienists and Dental Clinics.
Biolase has a B2B, B2B2C and E Commerce business model. Its revenue comes from Product Sales and Service Fee.
Biolase has approximately 410 employees.
Biolase has completed 13 funding rounds, raising a total of $121.08M. The latest funding stage is Post-IPO Debt.
Biolase offers: All-Tissue Lasers, Soft-Tissue Lasers, Dental Laser Training, Customer Service, Product Maintenance and Support.
Top alternatives and competitors to Biolase include LEIXIR DENTAL LABORATORY GROUP, DentlyTec. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biolase and LEIXIR DENTAL LABORATORY GROUP are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biolase, https://bouncewatch.com/company/biolase, updated 29 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes